BXP vs DNTH · rev $3.48B vs rev $6.2M
Boston Properties Inc (BXP) versus Dianthus Therapeutics Inc. (DNTH) — a side-by-side from cached financials, not a winner call.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
BXP currently screens at market cap $12.12B. DNTH currently screens at market cap $4.40B.
Not investment advice. Open the BXP and DNTH stock pages for the full models.
Not investment advice.